Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic

Archives of Dermatological Research

Volumn 304, Issue 1, 2012, Pages 7-13

  Velez, Nicole F ^a   Wei Passanese, Erin X ^b   Husni, M Elaine ^c   Mody, Elinor A ^a   Qureshi, Abrar A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; ETRETIN; INFLIXIMAB; METHOTREXATE;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; SMOKING HABIT; SYSTEMIC THERAPY; TREATMENT PLANNING;

ADULT; ARTHRITIS, PSORIATIC; COMORBIDITY; DERMATOLOGY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, SPECIAL; HUMANS; HYPERTENSION; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; RETROSPECTIVE STUDIES; RHEUMATOLOGY; UNITED STATES;

EID: 84856879531     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-011-1172-6     Document Type: Article

References (41)

1. NJ Bansback R Ara N Barkham A Brennan AD Fraser P Conway, et al. 2006 Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis Rheumatology 45 8 1029 1038 16782734 10.1093/rheumatology/kel147 1:CAS:528:DC%2BD28Xotl2rsrw%3D (Pubitemid 44283062)
2. L Barra JE Pope M Payne 2009 Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire J Rheumatol 36 7 1421 1428 19487267 10.3899/jrheum.081122
3. JM Berthelot M Klarlund D McGonagle HJ Bernelot-Moens A Calin B Harrison, et al. 2001 Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group J Rheumatol 28 5 975 981 11361225 1:STN:280:DC%2BD3M3nsVSgsA%3D%3D (Pubitemid 32422576)
4. S Boehncke S Fichtlscherer R Salgo J Garbaraviciene H Beschmann S Diehl, et al. 2011 Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial Arch Dermatol Res 303 6 381 388 21170539 10.1007/s00403-010-1108-6 1:CAS:528: DC%2BC3MXpt1Ciu7w%3D
5. V Chandran CT Schentag DD Gladman 2008 Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting J Rheumatol 35 10 2069 2070 18843760
6. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr, et al. 2003 The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 19 2560 2572 12748199 10.1001/jama.289.19.2560 1:CAS:528: DC%2BD3sXjvFCqtrk%3D (Pubitemid 37430158)
7. JR Curtis T Arora P Narongroeknawin A Taylor CO Bingham J Cush, et al. 2010 The delivery of evidence-based preventive care for older Americans with arthritis Arthritis Res Ther 12 4 R144 20637072 10.1186/ar3086
8. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults 2001 Executive summary of the third report of the national cholesterol education program (NCEP) JAMA 285 19 2486 2497 10.1001/jama.285.19. 2486
9. JF Fowler MS Duh L Rovba S Buteau L Pinheiro F Lobo, et al. 2008 The impact of psoriasis on health care costs and patient work loss J Am Acad Dermatol 59 5 772 780 19119095 10.1016/j.jaad.2008.06.043
10. JM Gelfand SR Feldman RS Stern J Thomas T Rolstad DJ Margolis 2004 Determinants of quality of life in patients with psoriasis: a study from the US population J Am Acad Dermatol 51 5 704 708 15523347 10.1016/j.jaad.2004.04.014 (Pubitemid 39516879)
11. JM Gelfand DD Gladman PJ Mease N Smith DJ Margolis T Nijsten, et al. 2005 Epidemiology of psoriatic arthritis in the population of the United States J Am Acad Dermatol 53 4 573 16198775 10.1016/j.jaad.2005.03.046 (Pubitemid 41399922)
12. JM Gelfand AL Neimann DB Shin X Wang DJ Margolis AB Troxel 2006 Risk of myocardial infarction in patients with psoriasis JAMA 296 14 1735 1741 17032986 10.1001/jama.296.14.1735 1:CAS:528:DC%2BD28XhtVyjs77F (Pubitemid 44547793)
13. DD Gladman VT Farewell K Wong J Husted 1998 Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death Arthritis Rheum 41 6 1103 1110 9627021 10.1002/1529- 0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N 1:STN:280:DyaK1c3ovVOisg%3D%3D (Pubitemid 28265412)
14. DD Gladman F Stafford-Brady CH Chang K Lewandowski ML Russell 1990 Longitudinal study of clinical and radiological progression in psoriatic arthritis J Rheumatol 17 6 809 812 2388203 1:STN:280:DyaK3czlsFSqsA%3D%3D (Pubitemid 20213507)
15. Gottlieb AB, Dann F (2009) Comorbidities in patients with psoriasis. Am J Med 122(12):1150 e1151-e1159
16. EJ Horn KM Fox V Patel CF Chiou F Dann M Lebwohl 2007 Association of patient-reported psoriasis severity with income and employment J Am Acad Dermatol 57 6 963 971 17761358 10.1016/j.jaad.2007.07.023 (Pubitemid 350087343)
17. G Ibrahim R Waxman PS Helliwell 2009 The prevalence of psoriatic arthritis in people with psoriasis Arthritis Rheum 61 10 1373 1378 19790120 10.1002/art.24608 1:STN:280:DC%2BD1MnovVShtg%3D%3D
18. D Kane L Stafford B Bresnihan O FitzGerald 2003 A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience Rheumatology 42 12 1460 1468 14523223 10.1093/rheumatology/keg384 1:STN:280:DC%2BD3srntFyhtw%3D%3D (Pubitemid 37508919)
19. A Kavanaugh CE Antoni GG Krueger S Yan M Bala LT Dooley, et al. 2006 Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis Ann Rheum Dis 65 4 471 477 16096330 10.1136/ard.2005.040196 1:CAS:528:DC%2BD28XjslWjtLc%3D
20. A Kavanaugh CE Antoni D Gladman S Wassenberg B Zhou A Beutler, et al. 2006 The infliximab multinational psoriatic arthritis controlled trial (IMPACT): results of radiographic analyses after 1 year Ann Rheum Dis 65 8 1038 1043 16439444 10.1136/ard.2005.045658 1:CAS:528:DC%2BD28XosFahurk%3D (Pubitemid 44133266)
21. AF Kavanaugh CT Ritchlin 2006 Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines J Rheumatol 33 7 1417 1421 16724373 (Pubitemid 44025162)
22. AB Kimball A Guerin M Tsaneva AP Yu EQ Wu SR Gupta, et al. 2011 Economic burden of comorbidities in patients with psoriasis is substantial J Eur Acad Dermatol Venereol 25 2 157 163 20561129 10.1111/j.1468-3083.2010.03730.x 1:STN:280:DC%2BC3M7isVSjtQ%3D%3D
23. SK Kurd JM Gelfand 2009 The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004 J Am Acad Dermatol 60 2 218 224 19022533 10.1016/j.jaad.2008.09.022
24. SK Kurd AB Troxel P Crits-Christoph JM Gelfand 2010 The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study Arch Dermatol 146 8 891 895 20713823 10.1001/archdermatol.2010.186
25. NJ McHugh C Balachrishnan SM Jones 2003 Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study Rheumatology 42 6 778 783 12730539 10.1093/rheumatology/keg217 1:STN:280:DC%2BD3s3kvVGltA%3D%3D (Pubitemid 37220911)
26. PJ Mease DD Gladman CT Ritchlin EM Ruderman SD Steinfeld EH Choy, et al. 2005 Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial Arthritis Rheum 52 10 3279 3289 16200601 10.1002/art.21306 1:CAS:528:DC%2BD2MXhtF2msrjP (Pubitemid 41447111)
27. PJ Mease AJ Kivitz FX Burch EL Siegel SB Cohen P Ory, et al. 2004 Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression Arthritis Rheum 50 7 2264 2272 15248226 10.1002/art.20335 1:CAS:528:DC%2BD2cXmsVansbc%3D (Pubitemid 38924405)
28. E Mody ME Husni P Schur AA Qureshi 2007 Multidisciplinary evaluation of patients with psoriasis presenting with musculoskeletal pain: a dermatology: rheumatology clinic experience Br J Dermatol 157 5 1050 1051 17725678 10.1111/j.1365-2133.2007.08139.x 1:STN:280:DC%2BD2sngvFOnsg%3D%3D (Pubitemid 47583493)
29. A Nast I Kopp M Augustin KB Banditt WH Boehncke M Follmann, et al. 2007 German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version) Arch Dermatol Res 299 3 111 138 17497162 10.1007/s00403-007-0744-y 1:STN:280:DC%2BD2szhs1Kqug%3D%3D (Pubitemid 46835379)
30. KB Onel K Onel 2010 Anti-tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders Arthritis Care Res 62 7 1024 1028 10.1002/acr.20228 1:CAS:528:DC%2BC3MXotlOisA%3D%3D
31. C Palazzi I Olivieri A Petricca C Salvarani 2002 Rheumatoid arthritis or psoriatic symmetric polyarthritis? A difficult differential diagnosis Clin Exp Rheumatol 20 1 3 4 11892705 1:STN:280:DC%2BD387mtFSrtg%3D%3D (Pubitemid 34213725)
32. S Prodanovich RS Kirsner JD Kravetz F Ma L Martinez DG Federman 2009 Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality Arch Dermatol 145 6 700 703 19528427 10.1001/archdermatol.2009.94
33. DA Regier N Bansback A Dar Santos CA Marra 2007 Cost-effectiveness of tumor necrosis factor-alpha antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis Expert Rev Pharmacoecon Outcome Res 7 2 155 169 10.1586/14737167.7.2.155 (Pubitemid 46681862)
34. AA Saad DM Ashcroft KD Watson DP Symmons PR Noyce KL Hyrich 2010 Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies Arthritis Care Res 62 3 345 353 10.1002/acr.20104
35. R Scarpa E Cosentini F Manguso A Oriente R Peluso M Atteno, et al. 2003 Clinical and genetic aspects of psoriatic arthritis "sine psoriasis" J Rheumatol 30 12 2638 2640 14719207 (Pubitemid 37549343)
36. Q Shang LS Tam GW Yip JE Sanderson Q Zhang EK Li, et al. 2011 High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis J Rheumatol 38 7 1363 1370 21459943 10.3899/jrheum.101136
37. DH Solomon TJ Love C Canning S Schneeweiss 2010 Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis Ann Rheum Dis 69 12 2114 2117 20584807 10.1136/ard.2009.125476
38. R Soltani-Arabshahi B Wong BJ Feng DE Goldgar KC Duffin GG Krueger 2010 Obesity in early adulthood as a risk factor for psoriatic arthritis Arch Dermatol 146 7 721 726 20644032 10.1001/archdermatol.2010.141
39. RS Stern T Nijsten SR Feldman DJ Margolis T Rolstad 2004 Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction J Investig Dermatol Symp Proc 9 2 136 139 15083780 10.1046/j.1087-0024.2003.09102.x (Pubitemid 38457271)
40. W Taylor D Gladman P Helliwell A Marchesoni P Mease H Mielants 2006 Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 54 8 2665 2673 16871531 10.1002/art.21972 (Pubitemid 44205029)
41. FC Wilson M Icen CS Crowson MT McEvoy SE Gabriel HM Kremers 2009 Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study Arthritis Rheum 61 2 233 239 19177544 10.1002/art.24172 1:CAS:528:DC%2BD1MXjtFKltbc%3D